Luis C. Pena
President & CEO at Evommune Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 10 months
- Director since
- 2025
10 months of board service in total across 1 board, counting each seat separately. Longest: Evommune Inc., 10 months.
Evommune Inc.
Director · President & CEO
Chief executive roles
Evommune Inc.
· President & CEO
Since November 2025
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 22, 2026 | Evommune Inc. | Open-market sale | −7,438 | $22.71 | $168,917 |
| Jun 1, 2026 | Evommune Inc. | Open-market sale | −16,787 | $22.74 | $381,736 |
| Dec 9, 2025 | Evommune Inc. | Shares withheld for tax | −28,138 | $17.84 | $501,982 |
| Nov 7, 2025 | Evommune Inc. | Derivative conversion | +24,225 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.